The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 01, 2012

Filed:

Apr. 26, 2010
Applicants:

Yasutsugu Ueda, Clinton, CT (US);

Timothy P. Connolly, Portland, CT (US);

John F. Kadow, Wallingford, CT (US);

Nicholas A. Meanwell, East Hampton, CT (US);

Tao Wang, Farmington, CT (US);

Chung-pin H. Chen, Madison, CT (US);

Kap-sun Yeung, Madison, CT (US);

Zhongxing Zhang, Madison, CT (US);

David Kenneth Leahy, Morristown, NJ (US);

Shawn K. Pack, Plainsboro, NJ (US);

Nachimuthu Soundararajan, Kendall Park, NJ (US);

Pierre Sirard, St. Jean sur Richelieu, CA;

Kathia Levesque, Ste-Catherine, CA;

Dominique Thoraval, Candiac, CA;

Inventors:

Yasutsugu Ueda, Clinton, CT (US);

Timothy P. Connolly, Portland, CT (US);

John F. Kadow, Wallingford, CT (US);

Nicholas A. Meanwell, East Hampton, CT (US);

Tao Wang, Farmington, CT (US);

Chung-Pin H. Chen, Madison, CT (US);

Kap-Sun Yeung, Madison, CT (US);

Zhongxing Zhang, Madison, CT (US);

David Kenneth Leahy, Morristown, NJ (US);

Shawn K. Pack, Plainsboro, NJ (US);

Nachimuthu Soundararajan, Kendall Park, NJ (US);

Pierre Sirard, St. Jean sur Richelieu, CA;

Kathia Levesque, Ste-Catherine, CA;

Dominique Thoraval, Candiac, CA;

Assignee:

Bristol-Myers Squibb Company, Princeton, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 57/00 (2006.01); A61K 31/675 (2006.01); C07D 401/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

This invention provides for prodrug Compounds I, pharmaceutical compositions thereof, and their use in treating HIV infection. wherein: Also, this invention provides for intermediate Compounds II useful in making prodrug Compounds I. wherein:


Find Patent Forward Citations

Loading…